Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

scientific article published on 10 October 2016

Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-16-1371
P932PMC publication ID5135610
P698PubMed publication ID27758888

P50authorMichiaki KuboQ42316443
Richard WeinshilboumQ52447985
Bingshu E. ChenQ56027887
Krishna R KalariQ57034862
Erin E CarlsonQ57034978
Vered StearnsQ87723624
Yoichi FurukawaQ88631928
Matthew J EllisQ88724457
Liewei WangQ89121645
James N IngleQ89668737
Poulami BarmanQ90864335
Yukihide MomozawaQ92225382
Matthew P GoetzQ95259846
P2093author name stringPaul E Goss
Fang Xie
Kathleen I Pritchard
Judith-Anne W Chapman
Lois E Shepherd
P2860cites workMechanisms of Endocrine Resistance in Breast CancerQ36851417
Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expressionQ36924856
Long noncoding RNAs and the genetics of cancer.Q36959100
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer preventionQ37009636
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathwayQ37515474
Biological determinants of endocrine resistance in breast cancerQ37585095
Mechanisms of aromatase inhibitor resistance.Q38439266
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer.Q38991643
The Inescapable Influence of Noncoding RNAs in CancerQ39927058
Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozoleQ40248483
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.Q50520130
A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase geneQ72710299
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP systemQ80358653
A genome-wide association study identifies protein quantitative trait loci (pQTLs)Q21145048
Population structure and eigenanalysisQ21145248
Complete sequencing and characterization of 21,243 full-length human cDNAsQ21735916
The landscape of long noncoding RNAs in the human transcriptomeQ22122065
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisQ24607308
Comprehensive molecular portraits of human breast tumoursQ24630844
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNAQ27011221
Genome regulation by long noncoding RNAs.Q27691812
Cancer statistics, 2015Q27860576
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataQ27860742
Principal components analysis corrects for stratification in genome-wide association studiesQ27860975
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Q27861047
Ligand-independent coactivation of ERalpha AF-1 by steroid receptor RNA activator (SRA) via MAPK activationQ28203998
A framework for variation discovery and genotyping using next-generation DNA sequencing dataQ29547262
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3Q29614852
Score tests for association between traits and haplotypes when linkage phase is ambiguousQ29616281
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaborationQ30514241
From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipelineQ30872351
Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cellsQ33614071
Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer.Q33962806
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomicsQ34265045
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trialsQ34486930
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitorsQ34488758
Long intergenic noncoding RNAs: new links in cancer progressionQ34676547
Human estrogen receptor-alpha: regulation by synthesis, modification and degradation.Q34712217
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifenQ35006860
The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation.Q35117450
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trialsQ35186747
A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.Q35574894
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasisQ36179588
Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator RegulationQ36632405
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesisQ36643119
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trialQ36729512
P433issue23
P407language of work or nameEnglishQ1860
P921main subjectpharmacogenomicsQ1152227
P304page(s)7012-7023
P577publication date2016-10-10
P1433published inCancer ResearchQ326097
P1476titleGenetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy
P478volume76

Reverse relations

cites work (P2860)
Q39453727'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.
Q45943221Breast cancer: The translation of big genomic data to cancer precision medicine.
Q44517598Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
Q51739091Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility.
Q39362053Genomic Insight into the Role of lncRNA in Cancer Susceptibility
Q38739248Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients.
Q41577349Immune Mediator Pharmacogenomics: TCL1A SNPs and Estrogen-Dependent Regulation of Inflammation
Q57106074Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
Q47258279Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
Q99419118Managing therapeutic resistance in breast cancer: from the lncRNAs perspective
Q47755674Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
Q96306239Significance of Single-Nucleotide Variants in Long Intergenic Non-protein Coding RNAs
Q89449268Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
Q88313233TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune
Q51415655TCL1A, a novel transcription factor and a co-regulator of NF-кB p65: SNP and estrogen-dependence.
Q94571038The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update
Q64079299The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1
Q93235559The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth
Q90435884The network of non-coding RNAs and their molecular targets in breast cancer
Q90023785WITHDRAWN: Single nucleotide polymorphism, a putative driver for the role of long intergeneric non-coding RNA